exocad releases PartialCAD for Partial Framework Design

Food and Healthcare Press Releases Wednesday April 11, 2018 14:50
DARMSTADT, Germany--11 Apr--PRNewswire/InfoQuest
exocad recently announced the commercial availability of its Partial Framework Design module.

exocad's PartialCAD provides unparalleled flexibility and design freedom thanks to its unique voxel-based technology. Tillmann Steinbrecher, CEO of exocad, says: "Our goal is that anything that can be made in wax, can also be designed with exocad. With this new module, even the most demanding experts in Removable Partial Dentures will find their design needs met."

Mr. Steinbrecher also points out that "the traditional process of creating partial frameworks is fully analog and both resource intensive and time consuming."   He says that "The PartialCAD module enables efficient production with 3d printers or milling machines, thus saving time and increasing productivity."

Partial Frameworks can be combined with crown and bridge designs, or other indications available in the exocad DentalCAD platform - e.g. for secondary structures on telescopic crowns, attachments, advanced implant cases, and more.

About exocad GmbH

exocad GmbH (exocad.com) is a dynamic and innovative software company committed to expanding the possibilities of digital dentistry and providing OEMs (Original Equipment Manufacturers) with flexible, reliable, and easy-to-use CAD/CAM software for dental labs and dental practices. exocad software has been chosen by leading OEMs worldwide for integration into their dental CAD/CAM offerings, and thousands of exocad DentalCAD licenses are sold each year. For more information and a list of exocad reseller partners, please visit exocad.com.

Photo - https://mma.prnewswire.com/media/665021/partial_framework_02.jpg

Latest Press Release

Merck and Pfizer Announce Discontinuation of Phase III JAVELIN Ovarian PARP 100 Trial in Previously Untreated Advanced Ovarian Cancer

Merck and Pfizer Inc. (NYSE: PFE) today announced the discontinuation of the ongoing Phase III JAVELIN Ovarian PARP 100 study evaluating the efficacy and safety of avelumab in combination with chemotherapy followed by maintenance therapy of avelumab in...

UK Schools Rank Last in Providing Oral Health Education, FDI Survey of 13 Countries Says

Today on World Oral Health Day (WOHD), FDI World Dental Federation (FDI) released the results of a survey from 13 countries, which asked parents with children aged 5–16 if their child's school provided lessons on good oral care. Poor oral health...

Merck Announces Collaboration With Iktos for Generative Artificial Intelligence (AI) Technology

- Collaboration agreement enables Merck access to Iktos AI technology across three drug discovery projects - Generative modelling AI technology enables rapid and cost-effective design of novel drugs - Agreement is part of Merck's R&D strategy to...

Oxford Nanopore Launches Flongle for Rapid, Smaller DNA/RNA Sequencing Tests in Any Environment

Oxford Nanopore has today made Flongle starter packs available to purchase https://store.nanoporetech.com/flongle.html, after initial testing in an early-access programme. Flongle introduces a new paradigm of smaller, on-demand DNA or RNA sequencing...

FDI: Endodontics White Paper Calls for Treatment to Consider Impact on Patient Health and Well-being

FDI World Dental Federation (FDI) released its first white paper on endodontic care today, providing an important resource for dentists, national dental associations (NDAs) and other oral health actors. (Logo:...

Related Topics